Literature DB >> 33806288

TRAIL Mediates Neuronal Death in AUD: A Link between Neuroinflammation and Neurodegeneration.

Liya Qin1, Jian Zou1, Alexandra Barnett1, Ryan P Vetreno1,2, Fulton T Crews1,2,3, Leon G Coleman1,3.   

Abstract

Although the cause of progressive neurodegeneration is often unclear, neuronal death can occur through several mechanisms. In conditions such as Alzheimer's or alcohol use disorder (AUD), Toll-like receptor (TLR) induction is observed with neurodegeneration. However, links between TLR activation and neurodegeneration are lacking. We report a role of apoptotic neuronal death in AUD through TLR7-mediated induction of death receptor signaling. In postmortem human cortex, a two-fold increase in apoptotic terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining in neurons was found in AUD versus controls. This occurred with the increased expression of TLR7 and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) death receptors. Binge ethanol treatment in C57BL/6 mice increased TLR7 and induced neuronal apoptosis in cortical regions that was blocked by TLR7 antagonism. Mechanistic studies in primary organotypic brain slice culture (OBSC) found that the inhibition of TLR7 and its endogenous ligand let-7b blocked ethanol-induced neuronal cell death. Both IMQ and ethanol induced the expression of TRAIL and its death receptor. In addition, TRAIL-neutralizing monoclonal antibodies blocked both imiquimod (IMQ) and ethanol induced neuronal death. These findings implicate TRAIL as a mediator of neuronal apoptosis downstream of TLR7 activation. TLR7 and neuronal apoptosis are implicated in other neurodegenerative diseases, including Alzheimer's disease. Therefore, TRAIL may represent a therapeutic target to slow neurodegeneration in multiple diseases.

Entities:  

Keywords:  TNFSF10; TRAIL; apoptosis; death receptors; neurodegeneration; toll-like receptor 7

Mesh:

Substances:

Year:  2021        PMID: 33806288      PMCID: PMC7961445          DOI: 10.3390/ijms22052547

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  84 in total

1.  Chronic, but not acute, nicotine exposure attenuates ethanol withdrawal-induced hippocampal damage in vitro.

Authors:  M A Prendergast; B R Harris; S Mayer; J M Littleton
Journal:  Alcohol Clin Exp Res       Date:  2000-10       Impact factor: 3.455

2.  The cerebral cortex is damaged in chronic alcoholics.

Authors:  J J Kril; G M Halliday; M D Svoboda; H Cartwright
Journal:  Neuroscience       Date:  1997-08       Impact factor: 3.590

3.  In vitro effects of ethanol withdrawal and spermidine on viability of hippocampus from male and female rat.

Authors:  M A Prendergast; B R Harris; J A Blanchard; S Mayer; D A Gibson; J M Littleton
Journal:  Alcohol Clin Exp Res       Date:  2000-12       Impact factor: 3.455

4.  High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence.

Authors:  Fulton T Crews; Liya Qin; Donna Sheedy; Ryan P Vetreno; Jian Zou
Journal:  Biol Psychiatry       Date:  2012-12-01       Impact factor: 13.382

Review 5.  The let-7 family of microRNAs.

Authors:  Sarah Roush; Frank J Slack
Journal:  Trends Cell Biol       Date:  2008-09-04       Impact factor: 20.808

6.  Acamprosate, MK-801, and ifenprodil inhibit neurotoxicity and calcium entry induced by ethanol withdrawal in organotypic slice cultures from neonatal rat hippocampus.

Authors:  Sveta Mayer; Barton R Harris; D Alex Gibson; John A Blanchard; Mark A Prendergast; Robert C Holley; John Littleton
Journal:  Alcohol Clin Exp Res       Date:  2002-10       Impact factor: 3.455

7.  Neuronal degeneration in rat cerebrocortical and olfactory regions during subchronic "binge" intoxication with ethanol: possible explanation for olfactory deficits in alcoholics.

Authors:  M A Collins; T D Corso; E J Neafsey
Journal:  Alcohol Clin Exp Res       Date:  1996-04       Impact factor: 3.455

8.  Anterior hippocampal volume deficits in nonamnesic, aging chronic alcoholics.

Authors:  E V Sullivan; L Marsh; D H Mathalon; K O Lim; A Pfefferbaum
Journal:  Alcohol Clin Exp Res       Date:  1995-02       Impact factor: 3.455

9.  Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer's disease.

Authors:  Katja Derkow; Rosa Rössling; Carola Schipke; Christina Krüger; Jakob Bauer; Michael Fähling; Andrea Stroux; Eckart Schott; Klemens Ruprecht; Oliver Peters; Seija Lehnardt
Journal:  PLoS One       Date:  2018-07-16       Impact factor: 3.240

Review 10.  The immune system on the TRAIL of Alzheimer's disease.

Authors:  Chiara Burgaletto; Antonio Munafò; Giulia Di Benedetto; Cettina De Francisci; Filippo Caraci; Rosaria Di Mauro; Claudio Bucolo; Renato Bernardini; Giuseppina Cantarella
Journal:  J Neuroinflammation       Date:  2020-10-13       Impact factor: 8.322

View more
  11 in total

Review 1.  Non-coding RNA in alcohol use disorder by affecting synaptic plasticity.

Authors:  Shuang Zhu; Jiaming Wu; Jian Hu
Journal:  Exp Brain Res       Date:  2022-01-13       Impact factor: 1.972

2.  Increased alcohol self-administration following repeated Toll-like receptor 3 agonist treatment in male and female rats.

Authors:  Dennis F Lovelock; Patrick A Randall; Kalynn Van Voorhies; Ryan P Vetreno; Fulton T Crews; Joyce Besheer
Journal:  Pharmacol Biochem Behav       Date:  2022-04-05       Impact factor: 3.697

3.  Increased Toll-like Receptor-MyD88-NFκB-Proinflammatory neuroimmune signaling in the orbitofrontal cortex of humans with alcohol use disorder.

Authors:  Ryan P Vetreno; Liya Qin; Leon G Coleman; Fulton T Crews
Journal:  Alcohol Clin Exp Res       Date:  2021-08-20       Impact factor: 3.928

4.  Chronic Ethanol Causes Persistent Increases in Alzheimer's Tau Pathology in Female 3xTg-AD Mice: A Potential Role for Lysosomal Impairment.

Authors:  Autumn E Tucker; Coral Del Mar Alicea Pauneto; Alexandra M Barnett; Leon G Coleman
Journal:  Front Behav Neurosci       Date:  2022-05-11       Impact factor: 3.617

5.  Neuroinflammation: The Pathogenic Mechanism of Neurological Disorders.

Authors:  Ali Gorji
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

6.  Ethanol Induces Secretion of Proinflammatory Extracellular Vesicles That Inhibit Adult Hippocampal Neurogenesis Through G9a/GLP-Epigenetic Signaling.

Authors:  Jian Zou; T Jordan Walter; Alexandra Barnett; Aaron Rohlman; Fulton T Crews; Leon G Coleman
Journal:  Front Immunol       Date:  2022-05-13       Impact factor: 8.786

7.  Systemic Administration of the TLR7/8 Agonist Resiquimod (R848) to Mice Is Associated with Transient, In Vivo-Detectable Brain Swelling.

Authors:  Natalie May Zahr; Qingyu Zhao; Ryan Goodcase; Adolf Pfefferbaum
Journal:  Biology (Basel)       Date:  2022-02-10

8.  Adolescent Binge Alcohol Enhances Early Alzheimer's Disease Pathology in Adulthood Through Proinflammatory Neuroimmune Activation.

Authors:  Alexandra Barnett; Emeraghi David; Aaron Rohlman; Viktoriya D Nikolova; Sheryl S Moy; Ryan P Vetreno; Leon G Coleman
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

9.  Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder.

Authors:  Ming-Fen Ho; Cheng Zhang; Irene Moon; Brandon J Coombes; Joanna Biernacka; Michelle Skime; Doo-Sup Choi; Paul E Croarkin; Mark A Frye; Quyen Ngo; Cedric Skillon; Tyler S Oesterle; Victor M Karpyak; Hu Li; Richard M Weinshilboum
Journal:  Front Pharmacol       Date:  2022-09-01       Impact factor: 5.988

Review 10.  Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs.

Authors:  Marissa Alvarez; Erick Trent; Bruno De Souza Goncalves; Duane G Pereira; Raghav Puri; Nicolas Anthony Frazier; Komal Sodhi; Sneha S Pillai
Journal:  Front Aging Neurosci       Date:  2022-10-04       Impact factor: 5.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.